STUART WASSER: Open Payments
NPI 1922099852 · ROCKVILLE CENTRE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 21 payments from 9 companies in 2025. Trend: 2023 $9,120 · 2024 $622 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 6 | $348 |
| Orexo US, Inc. | 4 | $86 |
| Lundbeck LLC | 3 | $72 |
| Indivior Inc. | 2 | $60 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Alkermes, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: BRIXADI, REXULTI, Zubsolv, SUBLOCADE, Auvelity, VIVITROL, CAPLYTA, UZEDY.
Industry payments across NY — which companies pay providers there.
